With Ed­i­tas' third CEO in as many years, ex­pect a new CMO and new de­vel­op­ment part­ners

Sarep­ta Ther­a­peu­tics CMO Gilmore O’Neill will take over as CEO and pres­i­dent of CRISPR biotech Ed­i­tas Med­i­cine on June 1.

But al­ready in the hours since be­ing an­nounced, O’Neill has been hear­ing from his net­work on who could po­ten­tial­ly be the new CMO at the gene edit­ing com­pa­ny he’s about to helm. Lisa Michaels was fired from the med­ical chief post in ear­ly Feb­ru­ary, with­out pub­lic ex­pla­na­tion, as part of a re­build­ing of the C-suite.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER